These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30403995)

  • 1. A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates.
    Keeffe JR; Van Rompay KKA; Olsen PC; Wang Q; Gazumyan A; Azzopardi SA; Schaefer-Babajew D; Lee YE; Stuart JB; Singapuri A; Watanabe J; Usachenko J; Ardeshir A; Saeed M; Agudelo M; Eisenreich T; Bournazos S; Oliveira TY; Rice CM; Coffey LL; MacDonald MR; Bjorkman PJ; Nussenzweig MC; Robbiani DF
    Cell Rep; 2018 Nov; 25(6):1385-1394.e7. PubMed ID: 30403995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
    Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques.
    Van Rompay KKA; Coffey LL; Kapoor T; Gazumyan A; Keesler RI; Jurado A; Peace A; Agudelo M; Watanabe J; Usachenko J; Singapuri A; Immareddy R; Ardeshir A; Stuart JB; Bournazos S; Ravetch JV; Balderes PJ; Lorenz IC; Esswein SR; Keeffe JR; Bjorkman PJ; Wang Q; Rice CM; MacDonald MR; Nussenzweig MC; Robbiani DF
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7981-7989. PubMed ID: 32209664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein.
    Bailey MJ; Broecker F; Freyn AW; Choi A; Brown JA; Fedorova N; Simon V; Lim JK; Evans MJ; García-Sastre A; Palese P; Tan GS
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31043537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.
    Zhao H; Xu L; Bombardi R; Nargi R; Deng Z; Errico JM; Nelson CA; Dowd KA; Pierson TC; Crowe JE; Diamond MS; Fremont DH
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
    Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
    Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.
    Esswein SR; Gristick HB; Jurado A; Peace A; Keeffe JR; Lee YE; Voll AV; Saeed M; Nussenzweig MC; Rice CM; Robbiani DF; MacDonald MR; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9865-9875. PubMed ID: 32321830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
    Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
    Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
    Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
    Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.
    Stettler K; Beltramello M; Espinosa DA; Graham V; Cassotta A; Bianchi S; Vanzetta F; Minola A; Jaconi S; Mele F; Foglierini M; Pedotti M; Simonelli L; Dowall S; Atkinson B; Percivalle E; Simmons CP; Varani L; Blum J; Baldanti F; Cameroni E; Hewson R; Harris E; Lanzavecchia A; Sallusto F; Corti D
    Science; 2016 Aug; 353(6301):823-6. PubMed ID: 27417494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?
    Gunawardana SA; Shaw RH
    BMC Infect Dis; 2018 Dec; 18(1):641. PubMed ID: 30526531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes.
    Sankhala RS; Dussupt V; Donofrio G; Gromowski GD; De La Barrera RA; Larocca RA; Mendez-Rivera L; Lee A; Choe M; Zaky W; Mantus G; Jensen JL; Chen WH; Gohain N; Bai H; McCracken MK; Mason RD; Leggat D; Slike BM; Tran U; Jian N; Abbink P; Peterson R; Mendes EA; Freitas de Oliveira Franca R; Calvet GA; Bispo de Filippis AM; McDermott A; Roederer M; Hernandez M; Albertus A; Davidson E; Doranz BJ; Rolland M; Robb ML; Lynch RM; Barouch DH; Jarman RG; Thomas SJ; Modjarrad K; Michael NL; Krebs SJ; Joyce MG
    Cell Rep; 2023 Aug; 42(8):112942. PubMed ID: 37561630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antibody response to Zika targets type-specific quaternary structure epitopes.
    Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
    Graham SD; Tu HA; McElvany BD; Graham NR; Grinyo A; Davidson E; Doranz BJ; Diehl SA; de Silva AM; Markmann AJ
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III.
    Wu Y; Li S; Du L; Wang C; Zou P; Hong B; Yuan M; Ren X; Tai W; Kong Y; Zhou C; Lu L; Zhou X; Jiang S; Ying T
    Emerg Microbes Infect; 2017 Oct; 6(10):e89. PubMed ID: 29018252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.